Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE) Article Swipe
Yuankai Shi
,
Jianhua Chen
,
Runxiang Yang
,
Hongbo Wu
,
Zhehai Wang
,
Weihua Yang
,
Jiuwei Cui
,
Yiping Zhang
,
Chunling Liu
,
Ying Cheng
,
Yunpeng Liu
,
Jinlu Shan
,
Donglin Wang
,
Lei Yang
,
Chang-Lu Hu
,
Jian Zhao
,
Ranhua Cao
,
Bangxian Tan
,
Ke Xu
,
Meimei Si
,
Hui Li
,
Ruifeng Mao
,
Lingyan Li
,
Xiaoyan Kang
,
Lin Wang
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1016/j.jtho.2024.01.013
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1016/j.jtho.2024.01.013
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.jtho.2024.01.013
- https://doi.org/10.1016/j.jtho.2024.01.013
- OA Status
- bronze
- Cited By
- 28
- References
- 29
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4391234256
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4391234256Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.jtho.2024.01.013Digital Object Identifier
- Title
-
Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE)Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-01-25Full publication date if available
- Authors
-
Yuankai Shi, Jianhua Chen, Runxiang Yang, Hongbo Wu, Zhehai Wang, Weihua Yang, Jiuwei Cui, Yiping Zhang, Chunling Liu, Ying Cheng, Yunpeng Liu, Jinlu Shan, Donglin Wang, Lei Yang, Chang-Lu Hu, Jian Zhao, Ranhua Cao, Bangxian Tan, Ke Xu, Meimei Si, Hui Li, Ruifeng Mao, Lingyan Li, Xiaoyan Kang, Lin WangList of authors in order
- Landing page
-
https://doi.org/10.1016/j.jtho.2024.01.013Publisher landing page
- PDF URL
-
https://doi.org/10.1016/j.jtho.2024.01.013Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.jtho.2024.01.013Direct OA link when available
- Concepts
-
Crizotinib, Medicine, Internal medicine, Adverse effect, Oncology, Incidence (geometry), Interim analysis, ALK inhibitor, Gastroenterology, Clinical trial, Lung cancer, Optics, Physics, Malignant pleural effusionTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
28Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 18, 2024: 10Per-year citation counts (last 5 years)
- References (count)
-
29Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4391234256 |
|---|---|
| doi | https://doi.org/10.1016/j.jtho.2024.01.013 |
| ids.doi | https://doi.org/10.1016/j.jtho.2024.01.013 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38280448 |
| ids.openalex | https://openalex.org/W4391234256 |
| fwci | 24.15344796 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D008297 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Male |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D005260 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Female |
| mesh[3].qualifier_ui | Q000188 |
| mesh[3].descriptor_ui | D002289 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | drug therapy |
| mesh[3].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[4].qualifier_ui | Q000473 |
| mesh[4].descriptor_ui | D002289 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | pathology |
| mesh[4].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[5].qualifier_ui | Q000235 |
| mesh[5].descriptor_ui | D002289 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | genetics |
| mesh[5].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[6].qualifier_ui | Q000188 |
| mesh[6].descriptor_ui | D008175 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | drug therapy |
| mesh[6].descriptor_name | Lung Neoplasms |
| mesh[7].qualifier_ui | Q000473 |
| mesh[7].descriptor_ui | D008175 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | pathology |
| mesh[7].descriptor_name | Lung Neoplasms |
| mesh[8].qualifier_ui | Q000235 |
| mesh[8].descriptor_ui | D008175 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | genetics |
| mesh[8].descriptor_name | Lung Neoplasms |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D008875 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Middle Aged |
| mesh[10].qualifier_ui | Q000627 |
| mesh[10].descriptor_ui | D000077547 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | therapeutic use |
| mesh[10].descriptor_name | Crizotinib |
| mesh[11].qualifier_ui | Q000494 |
| mesh[11].descriptor_ui | D000077547 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | pharmacology |
| mesh[11].descriptor_name | Crizotinib |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000328 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Adult |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D000368 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Aged |
| mesh[14].qualifier_ui | Q000627 |
| mesh[14].descriptor_ui | D047428 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | therapeutic use |
| mesh[14].descriptor_name | Protein Kinase Inhibitors |
| mesh[15].qualifier_ui | Q000494 |
| mesh[15].descriptor_ui | D047428 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | pharmacology |
| mesh[15].descriptor_name | Protein Kinase Inhibitors |
| mesh[16].qualifier_ui | Q000235 |
| mesh[16].descriptor_ui | D000077548 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | genetics |
| mesh[16].descriptor_name | Anaplastic Lymphoma Kinase |
| mesh[17].qualifier_ui | Q000037 |
| mesh[17].descriptor_ui | D000077548 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | antagonists & inhibitors |
| mesh[17].descriptor_name | Anaplastic Lymphoma Kinase |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D006801 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Humans |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D008297 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Male |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D005260 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Female |
| mesh[21].qualifier_ui | Q000188 |
| mesh[21].descriptor_ui | D002289 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | drug therapy |
| mesh[21].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[22].qualifier_ui | Q000473 |
| mesh[22].descriptor_ui | D002289 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | pathology |
| mesh[22].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[23].qualifier_ui | Q000235 |
| mesh[23].descriptor_ui | D002289 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | genetics |
| mesh[23].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[24].qualifier_ui | Q000188 |
| mesh[24].descriptor_ui | D008175 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | drug therapy |
| mesh[24].descriptor_name | Lung Neoplasms |
| mesh[25].qualifier_ui | Q000473 |
| mesh[25].descriptor_ui | D008175 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | pathology |
| mesh[25].descriptor_name | Lung Neoplasms |
| mesh[26].qualifier_ui | Q000235 |
| mesh[26].descriptor_ui | D008175 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | genetics |
| mesh[26].descriptor_name | Lung Neoplasms |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D008875 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Middle Aged |
| mesh[28].qualifier_ui | Q000627 |
| mesh[28].descriptor_ui | D000077547 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | therapeutic use |
| mesh[28].descriptor_name | Crizotinib |
| mesh[29].qualifier_ui | Q000494 |
| mesh[29].descriptor_ui | D000077547 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | pharmacology |
| mesh[29].descriptor_name | Crizotinib |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D000328 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Adult |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D000368 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Aged |
| mesh[32].qualifier_ui | Q000627 |
| mesh[32].descriptor_ui | D047428 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | therapeutic use |
| mesh[32].descriptor_name | Protein Kinase Inhibitors |
| mesh[33].qualifier_ui | Q000494 |
| mesh[33].descriptor_ui | D047428 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | pharmacology |
| mesh[33].descriptor_name | Protein Kinase Inhibitors |
| mesh[34].qualifier_ui | Q000235 |
| mesh[34].descriptor_ui | D000077548 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | genetics |
| mesh[34].descriptor_name | Anaplastic Lymphoma Kinase |
| mesh[35].qualifier_ui | Q000037 |
| mesh[35].descriptor_ui | D000077548 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | antagonists & inhibitors |
| mesh[35].descriptor_name | Anaplastic Lymphoma Kinase |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D006801 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Humans |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D008297 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Male |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D005260 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Female |
| mesh[39].qualifier_ui | Q000188 |
| mesh[39].descriptor_ui | D002289 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | drug therapy |
| mesh[39].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[40].qualifier_ui | Q000473 |
| mesh[40].descriptor_ui | D002289 |
| mesh[40].is_major_topic | True |
| mesh[40].qualifier_name | pathology |
| mesh[40].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[41].qualifier_ui | Q000235 |
| mesh[41].descriptor_ui | D002289 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | genetics |
| mesh[41].descriptor_name | Carcinoma, Non-Small-Cell Lung |
| mesh[42].qualifier_ui | Q000188 |
| mesh[42].descriptor_ui | D008175 |
| mesh[42].is_major_topic | True |
| mesh[42].qualifier_name | drug therapy |
| mesh[42].descriptor_name | Lung Neoplasms |
| mesh[43].qualifier_ui | Q000473 |
| mesh[43].descriptor_ui | D008175 |
| mesh[43].is_major_topic | True |
| mesh[43].qualifier_name | pathology |
| mesh[43].descriptor_name | Lung Neoplasms |
| mesh[44].qualifier_ui | Q000235 |
| mesh[44].descriptor_ui | D008175 |
| mesh[44].is_major_topic | True |
| mesh[44].qualifier_name | genetics |
| mesh[44].descriptor_name | Lung Neoplasms |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D008875 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Middle Aged |
| mesh[46].qualifier_ui | Q000627 |
| mesh[46].descriptor_ui | D000077547 |
| mesh[46].is_major_topic | True |
| mesh[46].qualifier_name | therapeutic use |
| mesh[46].descriptor_name | Crizotinib |
| mesh[47].qualifier_ui | Q000494 |
| mesh[47].descriptor_ui | D000077547 |
| mesh[47].is_major_topic | True |
| mesh[47].qualifier_name | pharmacology |
| mesh[47].descriptor_name | Crizotinib |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D000328 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Adult |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D000368 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Aged |
| type | article |
| title | Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE) |
| biblio.issue | 6 |
| biblio.volume | 19 |
| biblio.last_page | 927 |
| biblio.first_page | 912 |
| grants[0].funder | https://openalex.org/F4320321540 |
| grants[0].award_id | |
| grants[0].funder_display_name | Ministry of Science and Technology of the People's Republic of China |
| topics[0].id | https://openalex.org/T10417 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Lung Cancer Treatments and Mutations |
| topics[1].id | https://openalex.org/T11845 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9965999722480774 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Cancer therapeutics and mechanisms |
| topics[2].id | https://openalex.org/T12334 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9961000084877014 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Lung Cancer Research Studies |
| funders[0].id | https://openalex.org/F4320321540 |
| funders[0].ror | https://ror.org/027s68j25 |
| funders[0].display_name | Ministry of Science and Technology of the People's Republic of China |
| is_xpac | False |
| apc_list.value | 4000 |
| apc_list.currency | USD |
| apc_list.value_usd | 4000 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2779422266 |
| concepts[0].level | 4 |
| concepts[0].score | 0.9866373538970947 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q5186964 |
| concepts[0].display_name | Crizotinib |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.9090068340301514 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C126322002 |
| concepts[2].level | 1 |
| concepts[2].score | 0.7180454134941101 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[2].display_name | Internal medicine |
| concepts[3].id | https://openalex.org/C197934379 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5295572876930237 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[3].display_name | Adverse effect |
| concepts[4].id | https://openalex.org/C143998085 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5226454734802246 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[4].display_name | Oncology |
| concepts[5].id | https://openalex.org/C61511704 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5058662295341492 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1671857 |
| concepts[5].display_name | Incidence (geometry) |
| concepts[6].id | https://openalex.org/C61943457 |
| concepts[6].level | 3 |
| concepts[6].score | 0.4993131160736084 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q6046661 |
| concepts[6].display_name | Interim analysis |
| concepts[7].id | https://openalex.org/C2778347629 |
| concepts[7].level | 5 |
| concepts[7].score | 0.4847673773765564 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q4652380 |
| concepts[7].display_name | ALK inhibitor |
| concepts[8].id | https://openalex.org/C90924648 |
| concepts[8].level | 1 |
| concepts[8].score | 0.4280036389827728 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[8].display_name | Gastroenterology |
| concepts[9].id | https://openalex.org/C535046627 |
| concepts[9].level | 2 |
| concepts[9].score | 0.3133288621902466 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[9].display_name | Clinical trial |
| concepts[10].id | https://openalex.org/C2776256026 |
| concepts[10].level | 2 |
| concepts[10].score | 0.18845361471176147 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q47912 |
| concepts[10].display_name | Lung cancer |
| concepts[11].id | https://openalex.org/C120665830 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q14620 |
| concepts[11].display_name | Optics |
| concepts[12].id | https://openalex.org/C121332964 |
| concepts[12].level | 0 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[12].display_name | Physics |
| concepts[13].id | https://openalex.org/C2776232967 |
| concepts[13].level | 3 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q6743514 |
| concepts[13].display_name | Malignant pleural effusion |
| keywords[0].id | https://openalex.org/keywords/crizotinib |
| keywords[0].score | 0.9866373538970947 |
| keywords[0].display_name | Crizotinib |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.9090068340301514 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/internal-medicine |
| keywords[2].score | 0.7180454134941101 |
| keywords[2].display_name | Internal medicine |
| keywords[3].id | https://openalex.org/keywords/adverse-effect |
| keywords[3].score | 0.5295572876930237 |
| keywords[3].display_name | Adverse effect |
| keywords[4].id | https://openalex.org/keywords/oncology |
| keywords[4].score | 0.5226454734802246 |
| keywords[4].display_name | Oncology |
| keywords[5].id | https://openalex.org/keywords/incidence |
| keywords[5].score | 0.5058662295341492 |
| keywords[5].display_name | Incidence (geometry) |
| keywords[6].id | https://openalex.org/keywords/interim-analysis |
| keywords[6].score | 0.4993131160736084 |
| keywords[6].display_name | Interim analysis |
| keywords[7].id | https://openalex.org/keywords/alk-inhibitor |
| keywords[7].score | 0.4847673773765564 |
| keywords[7].display_name | ALK inhibitor |
| keywords[8].id | https://openalex.org/keywords/gastroenterology |
| keywords[8].score | 0.4280036389827728 |
| keywords[8].display_name | Gastroenterology |
| keywords[9].id | https://openalex.org/keywords/clinical-trial |
| keywords[9].score | 0.3133288621902466 |
| keywords[9].display_name | Clinical trial |
| keywords[10].id | https://openalex.org/keywords/lung-cancer |
| keywords[10].score | 0.18845361471176147 |
| keywords[10].display_name | Lung cancer |
| language | en |
| locations[0].id | doi:10.1016/j.jtho.2024.01.013 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S90745127 |
| locations[0].source.issn | 1556-0864, 1556-1380 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1556-0864 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Thoracic Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | https://doi.org/10.1016/j.jtho.2024.01.013 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Thoracic Oncology |
| locations[0].landing_page_url | https://doi.org/10.1016/j.jtho.2024.01.013 |
| locations[1].id | pmid:38280448 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38280448 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5100709250 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-3342-4964 |
| authorships[0].author.display_name | Yuankai Shi |
| authorships[0].countries | CN |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210115624 |
| authorships[0].affiliations[0].raw_affiliation_string | . Thoracic Medicine Department I, Hunan Tumor Hospital, Changsha, the People's Republic of China |
| authorships[0].institutions[0].id | https://openalex.org/I4210115624 |
| authorships[0].institutions[0].ror | https://ror.org/025020z88 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210115624 |
| authorships[0].institutions[0].country_code | CN |
| authorships[0].institutions[0].display_name | Hunan Cancer Hospital |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Yuankai Shi |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | . Thoracic Medicine Department I, Hunan Tumor Hospital, Changsha, the People's Republic of China |
| authorships[1].author.id | https://openalex.org/A5100385453 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-0326-3124 |
| authorships[1].author.display_name | Jianhua Chen |
| authorships[1].affiliations[0].raw_affiliation_string | . The Second Department of Medical Oncology, Yunnan Cancer Hospital, Kunming, China |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Jianhua Chen |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | . The Second Department of Medical Oncology, Yunnan Cancer Hospital, Kunming, China |
| authorships[2].author.id | https://openalex.org/A5101695246 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-3684-5892 |
| authorships[2].author.display_name | Runxiang Yang |
| authorships[2].countries | CN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210129412 |
| authorships[2].affiliations[0].raw_affiliation_string | of Department of Oncology, Anhui Provincial Cancer Hospital, Hefei, the People's Republic of China |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I4210143608 |
| authorships[2].affiliations[1].raw_affiliation_string | . Respiratory Intervention Department, Henan Cancer Hospital, Zhengzhou, the People's Republic of China |
| authorships[2].institutions[0].id | https://openalex.org/I4210129412 |
| authorships[2].institutions[0].ror | https://ror.org/03n5gdd09 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210129412 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Anhui Provincial Hospital |
| authorships[2].institutions[1].id | https://openalex.org/I4210143608 |
| authorships[2].institutions[1].ror | https://ror.org/043ek5g31 |
| authorships[2].institutions[1].type | healthcare |
| authorships[2].institutions[1].lineage | https://openalex.org/I4210143608 |
| authorships[2].institutions[1].country_code | CN |
| authorships[2].institutions[1].display_name | Henan Cancer Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Runxiang Yang |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | . Respiratory Intervention Department, Henan Cancer Hospital, Zhengzhou, the People's Republic of China, of Department of Oncology, Anhui Provincial Cancer Hospital, Hefei, the People's Republic of China |
| authorships[3].author.id | https://openalex.org/A5101319562 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Hongbo Wu |
| authorships[3].countries | CN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210100830, https://openalex.org/I4210163399 |
| authorships[3].affiliations[0].raw_affiliation_string | . Respiratory Medical Oncology Ward II, Shandong Cancer Hospital & Institute, Jinan, the People's Republic of China |
| authorships[3].institutions[0].id | https://openalex.org/I4210163399 |
| authorships[3].institutions[0].ror | https://ror.org/05jb9pq57 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210163399 |
| authorships[3].institutions[0].country_code | CN |
| authorships[3].institutions[0].display_name | Shandong First Medical University |
| authorships[3].institutions[1].id | https://openalex.org/I4210100830 |
| authorships[3].institutions[1].ror | https://ror.org/01413r497 |
| authorships[3].institutions[1].type | healthcare |
| authorships[3].institutions[1].lineage | https://openalex.org/I4210100830 |
| authorships[3].institutions[1].country_code | CN |
| authorships[3].institutions[1].display_name | Shandong Tumor Hospital |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Hongbo Wu |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | . Respiratory Medical Oncology Ward II, Shandong Cancer Hospital & Institute, Jinan, the People's Republic of China |
| authorships[4].author.id | https://openalex.org/A5047320009 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-7382-7274 |
| authorships[4].author.display_name | Zhehai Wang |
| authorships[4].countries | CN |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210102673 |
| authorships[4].affiliations[0].raw_affiliation_string | . Department of Respiratory, Shanxi Provincial Cancer Hospital, Taiyuan, the People's Republic of China |
| authorships[4].institutions[0].id | https://openalex.org/I4210102673 |
| authorships[4].institutions[0].ror | https://ror.org/01790dx02 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210102673 |
| authorships[4].institutions[0].country_code | CN |
| authorships[4].institutions[0].display_name | Shanxi Provincial Cancer Hospital |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Zhehai Wang |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | . Department of Respiratory, Shanxi Provincial Cancer Hospital, Taiyuan, the People's Republic of China |
| authorships[5].author.id | https://openalex.org/A5024929346 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-5468-758X |
| authorships[5].author.display_name | Weihua Yang |
| authorships[5].countries | CN |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I194450716, https://openalex.org/I4210125137 |
| authorships[5].affiliations[0].raw_affiliation_string | . Oncology Department, The First Hospital of Jilin University, Changchun, the People's Republic of China |
| authorships[5].institutions[0].id | https://openalex.org/I4210125137 |
| authorships[5].institutions[0].ror | https://ror.org/034haf133 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210125137 |
| authorships[5].institutions[0].country_code | CN |
| authorships[5].institutions[0].display_name | First Hospital of Jilin University |
| authorships[5].institutions[1].id | https://openalex.org/I194450716 |
| authorships[5].institutions[1].ror | https://ror.org/00js3aw79 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I194450716 |
| authorships[5].institutions[1].country_code | CN |
| authorships[5].institutions[1].display_name | Jilin University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Weihua Yang |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | . Oncology Department, The First Hospital of Jilin University, Changchun, the People's Republic of China |
| authorships[6].author.id | https://openalex.org/A5036233749 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-6496-7550 |
| authorships[6].author.display_name | Jiuwei Cui |
| authorships[6].countries | CN |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210098734 |
| authorships[6].affiliations[0].raw_affiliation_string | . Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China |
| authorships[6].institutions[0].id | https://openalex.org/I4210098734 |
| authorships[6].institutions[0].ror | https://ror.org/0144s0951 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210098734 |
| authorships[6].institutions[0].country_code | CN |
| authorships[6].institutions[0].display_name | Zhejiang Cancer Hospital |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Jiuwei Cui |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | . Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China |
| authorships[7].author.id | https://openalex.org/A5100773049 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-0577-027X |
| authorships[7].author.display_name | Yiping Zhang |
| authorships[7].countries | CN |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I154093214 |
| authorships[7].affiliations[0].raw_affiliation_string | . Pulmonary Medicine Ward II, The Affiliated Tumour Hospital of Xinjiang Medical University, Urumqi, the People's Republic of China |
| authorships[7].institutions[0].id | https://openalex.org/I154093214 |
| authorships[7].institutions[0].ror | https://ror.org/01p455v08 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I154093214 |
| authorships[7].institutions[0].country_code | CN |
| authorships[7].institutions[0].display_name | Xinjiang Medical University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Yiping Zhang |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | . Pulmonary Medicine Ward II, The Affiliated Tumour Hospital of Xinjiang Medical University, Urumqi, the People's Republic of China |
| authorships[8].author.id | https://openalex.org/A5100655223 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-0119-6255 |
| authorships[8].author.display_name | Chunling Liu |
| authorships[8].countries | CN |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210098607 |
| authorships[8].affiliations[0].raw_affiliation_string | . Thoracic Oncology Department, Jilin Cancer Hospital, Changchun, the People's Republic of China |
| authorships[8].institutions[0].id | https://openalex.org/I4210098607 |
| authorships[8].institutions[0].ror | https://ror.org/00vgek070 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210098607 |
| authorships[8].institutions[0].country_code | CN |
| authorships[8].institutions[0].display_name | Jilin Province Tumor Hospital |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Chunling Liu |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | . Thoracic Oncology Department, Jilin Cancer Hospital, Changchun, the People's Republic of China |
| authorships[9].author.id | https://openalex.org/A5057704753 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-9908-597X |
| authorships[9].author.display_name | Ying Cheng |
| authorships[9].countries | CN |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210140515, https://openalex.org/I91656880 |
| authorships[9].affiliations[0].raw_affiliation_string | . Department of Internal Medical Oncology, The First Hospital of China Medical University, Shenyang, the People's Republic of China |
| authorships[9].institutions[0].id | https://openalex.org/I91656880 |
| authorships[9].institutions[0].ror | https://ror.org/032d4f246 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I91656880 |
| authorships[9].institutions[0].country_code | CN |
| authorships[9].institutions[0].display_name | China Medical University |
| authorships[9].institutions[1].id | https://openalex.org/I4210140515 |
| authorships[9].institutions[1].ror | https://ror.org/04wjghj95 |
| authorships[9].institutions[1].type | healthcare |
| authorships[9].institutions[1].lineage | https://openalex.org/I4210140515 |
| authorships[9].institutions[1].country_code | CN |
| authorships[9].institutions[1].display_name | First Hospital of China Medical University |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Ying Cheng |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | . Department of Internal Medical Oncology, The First Hospital of China Medical University, Shenyang, the People's Republic of China |
| authorships[10].author.id | https://openalex.org/A5108058498 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-0959-0209 |
| authorships[10].author.display_name | Yunpeng Liu |
| authorships[10].countries | CN |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I151075929 |
| authorships[10].affiliations[0].raw_affiliation_string | . Oncology Department, Army Medical Center of PLA, Beijing, the People's Republic of China |
| authorships[10].institutions[0].id | https://openalex.org/I151075929 |
| authorships[10].institutions[0].ror | https://ror.org/05w21nn13 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I151075929 |
| authorships[10].institutions[0].country_code | CN |
| authorships[10].institutions[0].display_name | Army Medical University |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Yunpeng Liu |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | . Oncology Department, Army Medical Center of PLA, Beijing, the People's Republic of China |
| authorships[11].author.id | https://openalex.org/A5102273494 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Jinlu Shan |
| authorships[11].countries | CN |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I158842170, https://openalex.org/I4210154480 |
| authorships[11].affiliations[0].raw_affiliation_string | . Department of Internal Medical Oncology, Chongqing University Cancer Hospital, Chongqing, the People's Republic of China |
| authorships[11].institutions[0].id | https://openalex.org/I4210154480 |
| authorships[11].institutions[0].ror | https://ror.org/047d8yx24 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210154480 |
| authorships[11].institutions[0].country_code | CN |
| authorships[11].institutions[0].display_name | Chongqing Cancer Hospital |
| authorships[11].institutions[1].id | https://openalex.org/I158842170 |
| authorships[11].institutions[1].ror | https://ror.org/023rhb549 |
| authorships[11].institutions[1].type | education |
| authorships[11].institutions[1].lineage | https://openalex.org/I158842170 |
| authorships[11].institutions[1].country_code | CN |
| authorships[11].institutions[1].display_name | Chongqing University |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Jinlu Shan |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | . Department of Internal Medical Oncology, Chongqing University Cancer Hospital, Chongqing, the People's Republic of China |
| authorships[12].author.id | https://openalex.org/A5100665180 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-6897-2696 |
| authorships[12].author.display_name | Donglin Wang |
| authorships[12].countries | CN |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210114785 |
| authorships[12].affiliations[0].raw_affiliation_string | . Department of Respiratory Oncology, Gansu province Cancer Hospital, Lanzhou, the People's Republic of China 15. |
| authorships[12].institutions[0].id | https://openalex.org/I4210114785 |
| authorships[12].institutions[0].ror | https://ror.org/02axars19 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210114785 |
| authorships[12].institutions[0].country_code | CN |
| authorships[12].institutions[0].display_name | Gansu Provincial Hospital |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Donglin Wang |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | . Department of Respiratory Oncology, Gansu province Cancer Hospital, Lanzhou, the People's Republic of China 15. |
| authorships[13].author.id | https://openalex.org/A5015912374 |
| authorships[13].author.orcid | https://orcid.org/0000-0003-3718-2138 |
| authorships[13].author.display_name | Lei Yang |
| authorships[13].countries | CN, US |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I200296433, https://openalex.org/I4210126592 |
| authorships[13].affiliations[0].raw_affiliation_string | Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, |
| authorships[13].affiliations[1].institution_ids | https://openalex.org/I4210164898 |
| authorships[13].affiliations[1].raw_affiliation_string | No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, the People's Republic of China |
| authorships[13].institutions[0].id | https://openalex.org/I4210164898 |
| authorships[13].institutions[0].ror | https://ror.org/05anb7a53 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210164898 |
| authorships[13].institutions[0].country_code | CN |
| authorships[13].institutions[0].display_name | Beijing Chaoyang Emergency Medical Center |
| authorships[13].institutions[1].id | https://openalex.org/I200296433 |
| authorships[13].institutions[1].ror | https://ror.org/02drdmm93 |
| authorships[13].institutions[1].type | education |
| authorships[13].institutions[1].lineage | https://openalex.org/I200296433 |
| authorships[13].institutions[1].country_code | CN |
| authorships[13].institutions[1].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[13].institutions[2].id | https://openalex.org/I4210126592 |
| authorships[13].institutions[2].ror | https://ror.org/03ddkvp86 |
| authorships[13].institutions[2].type | facility |
| authorships[13].institutions[2].lineage | https://openalex.org/I4210126592 |
| authorships[13].institutions[2].country_code | US |
| authorships[13].institutions[2].display_name | National Clinical Research |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Lei Yang |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs,, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, the People's Republic of China |
| authorships[14].author.id | https://openalex.org/A5104110234 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Chang-Lu Hu |
| authorships[14].countries | CN |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I92039509 |
| authorships[14].affiliations[0].raw_affiliation_string | . Thoracic Surgery Department 1, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, the People's Republic of China |
| authorships[14].institutions[0].id | https://openalex.org/I92039509 |
| authorships[14].institutions[0].ror | https://ror.org/00zat6v61 |
| authorships[14].institutions[0].type | education |
| authorships[14].institutions[0].lineage | https://openalex.org/I92039509 |
| authorships[14].institutions[0].country_code | CN |
| authorships[14].institutions[0].display_name | Guangzhou Medical University |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Changlu Hu |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | . Thoracic Surgery Department 1, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, the People's Republic of China |
| authorships[15].author.id | https://openalex.org/A5070492885 |
| authorships[15].author.orcid | https://orcid.org/0000-0003-2617-4685 |
| authorships[15].author.display_name | Jian Zhao |
| authorships[15].countries | CN |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I44673925 |
| authorships[15].affiliations[0].raw_affiliation_string | . Department of Internal Medical Oncology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, the People's Republic of China |
| authorships[15].institutions[0].id | https://openalex.org/I44673925 |
| authorships[15].institutions[0].ror | https://ror.org/01mtxmr84 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I44673925 |
| authorships[15].institutions[0].country_code | CN |
| authorships[15].institutions[0].display_name | Inner Mongolia Medical University |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Jian Zhao |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | . Department of Internal Medical Oncology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, the People's Republic of China |
| authorships[16].author.id | https://openalex.org/A5061168558 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Ranhua Cao |
| authorships[16].countries | CN |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I4210108565 |
| authorships[16].affiliations[0].raw_affiliation_string | . Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, the People's Republic of China |
| authorships[16].institutions[0].id | https://openalex.org/I4210108565 |
| authorships[16].institutions[0].ror | https://ror.org/01673gn35 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I4210108565 |
| authorships[16].institutions[0].country_code | CN |
| authorships[16].institutions[0].display_name | Affiliated Hospital of North Sichuan Medical College |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Ranhua Cao |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | . Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, the People's Republic of China |
| authorships[17].author.id | https://openalex.org/A5019092913 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Bangxian Tan |
| authorships[17].countries | CN |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210129412 |
| authorships[17].affiliations[0].raw_affiliation_string | . Department of Respiratory, Anhui Provincial Cancer Hospital, Hefei, the People's Republic of China |
| authorships[17].institutions[0].id | https://openalex.org/I4210129412 |
| authorships[17].institutions[0].ror | https://ror.org/03n5gdd09 |
| authorships[17].institutions[0].type | healthcare |
| authorships[17].institutions[0].lineage | https://openalex.org/I4210129412 |
| authorships[17].institutions[0].country_code | CN |
| authorships[17].institutions[0].display_name | Anhui Provincial Hospital |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Bangxian Tan |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | . Department of Respiratory, Anhui Provincial Cancer Hospital, Hefei, the People's Republic of China |
| authorships[18].author.id | https://openalex.org/A5100666261 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-7689-750X |
| authorships[18].author.display_name | Ke Xu |
| authorships[18].affiliations[0].raw_affiliation_string | . Clinical Research Center, Qilu Pharmaceutical Co., Ltd, Jinan, the People's Republic of China |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Ke Xu |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | . Clinical Research Center, Qilu Pharmaceutical Co., Ltd, Jinan, the People's Republic of China |
| authorships[19].author.id | https://openalex.org/A5022225580 |
| authorships[19].author.orcid | https://orcid.org/0000-0001-6564-0058 |
| authorships[19].author.display_name | Meimei Si |
| authorships[19].affiliations[0].raw_affiliation_string | . Clinical Research Center, Qilu Pharmaceutical Co., Ltd, Jinan, the People's Republic of China |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Meimei Si |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | . Clinical Research Center, Qilu Pharmaceutical Co., Ltd, Jinan, the People's Republic of China |
| authorships[20].author.id | https://openalex.org/A5100423990 |
| authorships[20].author.orcid | https://orcid.org/0000-0003-4212-9155 |
| authorships[20].author.display_name | Hui Li |
| authorships[20].affiliations[0].raw_affiliation_string | . Clinical Research Center, Qilu Pharmaceutical Co., Ltd, Jinan, the People's Republic of China |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Hui Li |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | . Clinical Research Center, Qilu Pharmaceutical Co., Ltd, Jinan, the People's Republic of China |
| authorships[21].author.id | https://openalex.org/A5057791895 |
| authorships[21].author.orcid | https://orcid.org/0000-0001-7596-6713 |
| authorships[21].author.display_name | Ruifeng Mao |
| authorships[21].affiliations[0].raw_affiliation_string | . Clinical Research Center, Qilu Pharmaceutical Co., Ltd, Jinan, the People's Republic of China |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Ruifeng Mao |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | . Clinical Research Center, Qilu Pharmaceutical Co., Ltd, Jinan, the People's Republic of China |
| authorships[22].author.id | https://openalex.org/A5062023507 |
| authorships[22].author.orcid | https://orcid.org/0000-0003-2549-5874 |
| authorships[22].author.display_name | Lingyan Li |
| authorships[22].countries | CN, US |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I4210164898 |
| authorships[22].affiliations[0].raw_affiliation_string | No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, the People's Republic of China |
| authorships[22].affiliations[1].institution_ids | https://openalex.org/I200296433, https://openalex.org/I4210126592 |
| authorships[22].affiliations[1].raw_affiliation_string | Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, |
| authorships[22].institutions[0].id | https://openalex.org/I4210164898 |
| authorships[22].institutions[0].ror | https://ror.org/05anb7a53 |
| authorships[22].institutions[0].type | healthcare |
| authorships[22].institutions[0].lineage | https://openalex.org/I4210164898 |
| authorships[22].institutions[0].country_code | CN |
| authorships[22].institutions[0].display_name | Beijing Chaoyang Emergency Medical Center |
| authorships[22].institutions[1].id | https://openalex.org/I200296433 |
| authorships[22].institutions[1].ror | https://ror.org/02drdmm93 |
| authorships[22].institutions[1].type | education |
| authorships[22].institutions[1].lineage | https://openalex.org/I200296433 |
| authorships[22].institutions[1].country_code | CN |
| authorships[22].institutions[1].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[22].institutions[2].id | https://openalex.org/I4210126592 |
| authorships[22].institutions[2].ror | https://ror.org/03ddkvp86 |
| authorships[22].institutions[2].type | facility |
| authorships[22].institutions[2].lineage | https://openalex.org/I4210126592 |
| authorships[22].institutions[2].country_code | US |
| authorships[22].institutions[2].display_name | National Clinical Research |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Lingyan Li |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs,, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, the People's Republic of China |
| authorships[23].author.id | https://openalex.org/A5073614729 |
| authorships[23].author.orcid | https://orcid.org/0009-0001-5947-0205 |
| authorships[23].author.display_name | Xiaoyan Kang |
| authorships[23].countries | CN, US |
| authorships[23].affiliations[0].raw_affiliation_string | . Clinical Research Center, Qilu Pharmaceutical Co., Ltd, Jinan, the People's Republic of China |
| authorships[23].affiliations[1].institution_ids | https://openalex.org/I4210126592 |
| authorships[23].affiliations[1].raw_affiliation_string | . Department of Medical Oncology, National Cancer Center/National Clinical Research |
| authorships[23].affiliations[2].institution_ids | https://openalex.org/I200296433 |
| authorships[23].affiliations[2].raw_affiliation_string | Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, the People's Republic of China |
| authorships[23].institutions[0].id | https://openalex.org/I200296433 |
| authorships[23].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[23].institutions[0].type | education |
| authorships[23].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[23].institutions[0].country_code | CN |
| authorships[23].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[23].institutions[1].id | https://openalex.org/I4210126592 |
| authorships[23].institutions[1].ror | https://ror.org/03ddkvp86 |
| authorships[23].institutions[1].type | facility |
| authorships[23].institutions[1].lineage | https://openalex.org/I4210126592 |
| authorships[23].institutions[1].country_code | US |
| authorships[23].institutions[1].display_name | National Clinical Research |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Xiaoyan Kang |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | . Clinical Research Center, Qilu Pharmaceutical Co., Ltd, Jinan, the People's Republic of China, . Department of Medical Oncology, National Cancer Center/National Clinical Research, Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, the People's Republic of China |
| authorships[24].author.id | https://openalex.org/A5100735511 |
| authorships[24].author.orcid | https://orcid.org/0000-0003-2433-8594 |
| authorships[24].author.display_name | Lin Wang |
| authorships[24].countries | CN, US |
| authorships[24].affiliations[0].institution_ids | https://openalex.org/I4210126592 |
| authorships[24].affiliations[0].raw_affiliation_string | . Department of Medical Oncology, National Cancer Center/National Clinical Research |
| authorships[24].affiliations[1].institution_ids | https://openalex.org/I200296433 |
| authorships[24].affiliations[1].raw_affiliation_string | Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, the People's Republic of China |
| authorships[24].institutions[0].id | https://openalex.org/I200296433 |
| authorships[24].institutions[0].ror | https://ror.org/02drdmm93 |
| authorships[24].institutions[0].type | education |
| authorships[24].institutions[0].lineage | https://openalex.org/I200296433 |
| authorships[24].institutions[0].country_code | CN |
| authorships[24].institutions[0].display_name | Chinese Academy of Medical Sciences & Peking Union Medical College |
| authorships[24].institutions[1].id | https://openalex.org/I4210126592 |
| authorships[24].institutions[1].ror | https://ror.org/03ddkvp86 |
| authorships[24].institutions[1].type | facility |
| authorships[24].institutions[1].lineage | https://openalex.org/I4210126592 |
| authorships[24].institutions[1].country_code | US |
| authorships[24].institutions[1].display_name | National Clinical Research |
| authorships[24].author_position | last |
| authorships[24].raw_author_name | Lin Wang |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | . Department of Medical Oncology, National Cancer Center/National Clinical Research, Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, the People's Republic of China |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.jtho.2024.01.013 |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Iruplinalkib (WX-0593) Versus Crizotinib in ALK TKI-Naive Locally Advanced or Metastatic ALK-Positive NSCLC: Interim Analysis of a Randomized, Open-Label, Phase 3 Study (INSPIRE) |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10417 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Lung Cancer Treatments and Mutations |
| related_works | https://openalex.org/W2439017782, https://openalex.org/W2126298634, https://openalex.org/W1983845822, https://openalex.org/W2533300620, https://openalex.org/W3007665819, https://openalex.org/W4388084067, https://openalex.org/W2462717932, https://openalex.org/W2177936014, https://openalex.org/W3133715893, https://openalex.org/W2057269827 |
| cited_by_count | 28 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 18 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 10 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1016/j.jtho.2024.01.013 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S90745127 |
| best_oa_location.source.issn | 1556-0864, 1556-1380 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1556-0864 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Journal of Thoracic Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://doi.org/10.1016/j.jtho.2024.01.013 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Thoracic Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.jtho.2024.01.013 |
| primary_location.id | doi:10.1016/j.jtho.2024.01.013 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S90745127 |
| primary_location.source.issn | 1556-0864, 1556-1380 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1556-0864 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Thoracic Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | https://doi.org/10.1016/j.jtho.2024.01.013 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Thoracic Oncology |
| primary_location.landing_page_url | https://doi.org/10.1016/j.jtho.2024.01.013 |
| publication_date | 2024-01-25 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2515048758, https://openalex.org/W4295079305, https://openalex.org/W2782740441, https://openalex.org/W2055402151, https://openalex.org/W2104830962, https://openalex.org/W2581996620, https://openalex.org/W2624310346, https://openalex.org/W2894476389, https://openalex.org/W3101089668, https://openalex.org/W3196750844, https://openalex.org/W4223654428, https://openalex.org/W4363645814, https://openalex.org/W4210807404, https://openalex.org/W4321791325, https://openalex.org/W2060499368, https://openalex.org/W4252867417, https://openalex.org/W4317761498, https://openalex.org/W2991400485, https://openalex.org/W2939690516, https://openalex.org/W4385791566, https://openalex.org/W2099530756, https://openalex.org/W2793611408, https://openalex.org/W3133838590, https://openalex.org/W2938245541, https://openalex.org/W2902262211, https://openalex.org/W4310219785, https://openalex.org/W4286511207, https://openalex.org/W6850840673, https://openalex.org/W4323923054 |
| referenced_works_count | 29 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 99 |
| corresponding_author_ids | https://openalex.org/A5100709250 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 25 |
| corresponding_institution_ids | https://openalex.org/I4210115624 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7300000190734863 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.99409043 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |